Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Cash from Financing Activities (2024 - 2025)

Historic Cash from Financing Activities for Dr Reddys Laboratories (RDY) over the last 2 years, with Q3 2025 value amounting to -$61.0 million.

  • Dr Reddys Laboratories' Cash from Financing Activities fell 13164.17% to -$61.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $232.1 million, marking a year-over-year decrease of 3229.18%. This contributed to the annual value of $222.0 million for FY2025, which is 59333.33% up from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Cash from Financing Activities of -$61.0 million as of Q3 2025, which was down 13164.17% from -$14.1 million recorded in Q2 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Cash from Financing Activities peaked at $192.8 million during Q3 2024, and registered a low of -$61.0 million during Q3 2025.